Related Experiment Video

Updated: Oct 24, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Skin lesions in chronic granulocytic leukemia. Treatment of a patient with topical nitrogen mustard

W G Murphy, G H Fotheringham, A Busuttil

    Cancer
    |June 1, 1985
    PubMed

    Abstract:

    A patient is described with an unusual presentation of ulcerating skin lesions in Philadelphia chromosome-positive chronic granulocytic leukaemia. Treatment with topical mustine ointment (nitrogen mustard, mechlorethamine) achieved a good palliative result.

    More Related Videos

    A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
    07:22

    A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

    Published on: March 14, 2025

    A Video Protocol of a Randomized Controlled Clinical Trial - Electrochemotherapy of Cutaneous Metastases with Reduced Dose Bleomycin (BLESS Trial)
    04:11

    A Video Protocol of a Randomized Controlled Clinical Trial - Electrochemotherapy of Cutaneous Metastases with Reduced Dose Bleomycin (BLESS Trial)

    Published on: June 9, 2026

    Related Experiment Videos

    Last Updated: Oct 24, 2026

    The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
    11:39

    The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

    Published on: July 11, 2013

    A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
    07:22

    A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

    Published on: March 14, 2025

    A Video Protocol of a Randomized Controlled Clinical Trial - Electrochemotherapy of Cutaneous Metastases with Reduced Dose Bleomycin (BLESS Trial)
    04:11

    A Video Protocol of a Randomized Controlled Clinical Trial - Electrochemotherapy of Cutaneous Metastases with Reduced Dose Bleomycin (BLESS Trial)

    Published on: June 9, 2026

    Related Concept Videos

    Skin Cancer01:30

    Skin Cancer

    Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
    Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

    Articles linked to this work by shared authors, journal, and citation graph.

    Editor's Choice-- A Systematic Review of Endovenous Stenting in Chronic Venous Disease Secondary to Iliac Vein Obstruction.

    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2015

    Lessons from the response to the threat of transfusion-transmitted vCJD in Ireland.

    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2013

    Pathogen reduction: state of reflection in Ireland.

    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2011

    Phase I/II safety study of transfusion of prion-filtered red cell concentrates in transfusion-dependent patients.

    Vox sanguinis·2010

    Capillary and venous haemoglobin levels in blood donors: a 42-month study of 36,258 paired samples.

    Vox sanguinis·2009

    In vitro assessment of red-cell concentrates in SAG-M filtered through the MacoPharma P-CAPT prion-reduction filter.

    Transfusion medicine (Oxford, England)·2009

    Patterns of physical activity and health care costs in older individuals with a history of cancer.

    Cancer·2026

    Real-world outcomes in circulating tumor DNA-detected isocitrate dehydrogenase 1-mutant cholangiocarcinoma: First-line gemcitabine and cisplatin with versus without immunotherapy.

    Cancer·2026

    Cancer risks associated with BRCA1 and BRCA2: Overview and management.

    Cancer·2026

    Blood-based biomarkers in patients with recurrent, persistent, or metastatic endometrial cancer treated with olaparib and cediranib: Results from NRG-GY012.

    Cancer·2026

    Evolving role of proton therapy in contemporary oncology.

    Cancer·2026

    Evaluation of early C-reactive protein kinetics as an early response marker in biliary tract cancer treated with combined chemoimmunotherapy: A multicenter observational study.

    Cancer·2026

    The role of personalised medicine in treating high-risk neuroblastoma in paediatric patients.

    Oncology reviews·2026

    Spatial organization of neutrophil and macrophage populations in surgically treated hepatocellular carcinoma: a practical tissue-based immunophenotyping study.

    Frontiers in immunology·2026

    HIV-associated extranodal NK/T cell lymphoma, nasal type: a case report and literature review.

    Frontiers in immunology·2026

    Stathmin 1 regulates mitophagy and non-proliferative cellular function in hematopoietic stem and progenitor cells.

    iScience·2026

    Hybrid surgical thromboembolectomy and crossover endovascular revascularization for acute lower-limb ischemia in a patient with active ovarian cancer receiving a PARP inhibitor (fuzuloparib): a case report and literature review.

    Frontiers in cardiovascular medicine·2026

    Targeting PRMT5 with indole-based arylsulfonylhydrazides: a novel epigenetic strategy for the treatment of acute and chronic leukemia.

    American journal of cancer research·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us